127 related articles for article (PubMed ID: 31150720)
41. Zhen-wu-tang protects against podocyte injury in rats with IgA nephropathy via PPARγ/NF-κB pathway.
Liu B; He Y; Lu R; Zhou J; Bai L; Zhang P; Ye S; Wu J; Liang C; Zhou Y; Zhou J
Biomed Pharmacother; 2018 May; 101():635-647. PubMed ID: 29518610
[TBL] [Abstract][Full Text] [Related]
42. Resveratrol alleviates obesity-associated podocyte injury in ovariectomized obese rats.
Li B; Xiao X; Miao Y; Guo L; Zhen J; Li X; Jiang B; Hu Z
Exp Ther Med; 2020 Jan; 19(1):123-130. PubMed ID: 31853281
[TBL] [Abstract][Full Text] [Related]
43. Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats.
Lv W; Zhang Y; Guan G; Li P; Wang J; Qi D
Pharmacology; 2013; 92(3-4):227-34. PubMed ID: 24158161
[TBL] [Abstract][Full Text] [Related]
44. Effects of ROS-relative NF-κB signaling on high glucose-induced TLR4 and MCP-1 expression in podocyte injury.
Wei M; Li Z; Xiao L; Yang Z
Mol Immunol; 2015 Dec; 68(2 Pt A):261-71. PubMed ID: 26364141
[TBL] [Abstract][Full Text] [Related]
45. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
[TBL] [Abstract][Full Text] [Related]
46. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
Zhu L; Han J; Yuan R; Xue L; Pang W
Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
[TBL] [Abstract][Full Text] [Related]
47. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
48. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
Jin J; Ye M; Hu K; Gong J; He Q
Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
[TBL] [Abstract][Full Text] [Related]
49. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
Jung E; Kim J; Ho Kim S; Kim S; Cho MH
Eur J Pharmacol; 2015 Aug; 761():116-24. PubMed ID: 25977232
[TBL] [Abstract][Full Text] [Related]
50. 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes.
Catanuto P; Doublier S; Lupia E; Fornoni A; Berho M; Karl M; Striker GE; Xia X; Elliot S
Kidney Int; 2009 Jun; 75(11):1194-1201. PubMed ID: 19279558
[TBL] [Abstract][Full Text] [Related]
51. Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression.
Liebisch M; Bondeva T; Franke S; Daniel C; Amann K; Wolf G
Kidney Int; 2014 Jul; 86(1):103-17. PubMed ID: 24476693
[TBL] [Abstract][Full Text] [Related]
52. Human umbilical cord mesenchymal stem cells improve the reserve function of perimenopausal ovary via a paracrine mechanism.
Li J; Mao Q; He J; She H; Zhang Z; Yin C
Stem Cell Res Ther; 2017 Mar; 8(1):55. PubMed ID: 28279229
[TBL] [Abstract][Full Text] [Related]
53. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
54. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
Wang S; Li Y; Huang YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
[TBL] [Abstract][Full Text] [Related]
55. TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice.
Lian H; Cheng Y; Wu X
Biochem Biophys Res Commun; 2017 May; 487(2):201-208. PubMed ID: 28392397
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
57. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
Li Y; Liu J; Liao G; Zhang J; Chen Y; Li L; Li L; Liu F; Chen B; Guo G; Wang C; Yang L; Cheng J; Lu Y
Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379
[TBL] [Abstract][Full Text] [Related]
58. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
59. Resveratrol Prevents the Cellular Damages Induced by Monocrotophos via PI3K Signaling Pathway in Human Cord Blood Mesenchymal Stem Cells.
Jahan S; Kumar D; Singh S; Kumar V; Srivastava A; Pandey A; Rajpurohit CS; Khanna VK; Pant AB
Mol Neurobiol; 2018 Nov; 55(11):8278-8292. PubMed ID: 29526017
[TBL] [Abstract][Full Text] [Related]
60. [Regulatory Effect of Chinese Drugs for Stasis Removing and Collaterals Dredging on the Expres- sions of podocin and CD2AP in Podocyte Slit Diaphragm of Diabetic Nephropathy Rats].
Fang J; Chen ZQ; Guo Q; Chen CY; Wang CN; Xie T; Sun R; Liu LF; Zhang X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):835-841. PubMed ID: 30634212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
